SCHEMBL21783395

SCHEMBL21783395

COc1ccc(CN(Sc2ccc(F)c(C)n2)c2cccc(F)n2)c(OC)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.36
MEN1 O00255 6/20 0.36
ALDH1A1 P00352 3/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
DHFR P00374 1/20 0.35
KDM4E B2RXH2 4/20 0.34
TSHR P16473 5/20 0.33
LMNA P02545 2/20 0.33
APLNR P35414 1/20 0.33
POLB P06746 1/20 0.32
CYP1A2 P05177 3/20 0.32
CYP3A4 P08684 3/20 0.32
CYP2D6 P10635 3/20 0.32
CYP2C19 P33261 2/20 0.32
CLK4 Q9HAZ1 1/20 0.32
USP2 O75604 1/20 0.32
GAA P10253 1/20 0.32
NPC1 O15118 1/20 0.31
PKM P14618 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21783377 0.85 MEN1 (0.37) KMT2AMEN1ALDH1A1HTTSMN1; SMN2
SCHEMBL21783444 0.84 KMT2A (0.37) KMT2AMEN1ALDH1A1HTTSMN1; SMN2
SCHEMBL20256741 0.83 KMT2A (0.35) KMT2AMEN1ALDH1A1HTTSMN1; SMN2
SCHEMBL19634018 0.82 MEN1 (0.39) KMT2AMEN1ALDH1A1HTTSMN1; SMN2
SCHEMBL21794007 0.81 GAA (0.42) KMT2AMEN1ALDH1A1HTTSMN1; SMN2
SCHEMBL21783480 0.80 SCN8A (0.51) CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL19633951 0.80 KMT2A (0.36) KMT2AMEN1ALDH1A1HTTSMN1; SMN2
SCHEMBL19634258 0.80 HTR2A (0.38) KMT2AMEN1ALDH1A1HTTSMN1; SMN2
SCHEMBL19634006 0.79 DHFR (0.36) KMT2AMEN1ALDH1A1HTTSMN1; SMN2
SCHEMBL19634254 0.79 KMT2A (0.37) KMT2AMEN1ALDH1A1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020047323-A1 HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2020-03-05 WO disclosed